Department of Obstetrics and Gynecology, Duke University Health System, Durham, NC (Dr Denoble, Ms Weaver, and Dr Dotters-Katz).
Duke University School of Medicine, Duke University Health System, Durham, NC (Mses Reid, Krischak, and Sachdeva).
Am J Obstet Gynecol MFM. 2022 Mar;4(2):100540. doi: 10.1016/j.ajogmf.2021.100540. Epub 2021 Nov 29.
The introduction of antibiotics has significantly reduced morbidity and mortality from microbial infections, but the rise of antibiotic-resistant and multidrug-resistant microbes is of increasing clinical concern. Few studies have examined the prevalence and impact of antibiotic resistance in common antenatal infections.
This study aimed to determine whether pregnant women with a urine culture positive for antibiotic-resistant or multidrug-resistant gram-negative bacteria are at increased risk of developing pyelonephritis than pregnant women infected with antibiotic-susceptible organisms.
This was a retrospective cohort study of pregnant women with asymptomatic bacteriuria or acute cystitis from a single health system from July 2013 to May 2019. Women with gram-negative antibiotic-resistant (resistance to 1-2 antibiotic classes) and multidrug-resistant (resistance to ≥3 antibiotic classes) lower urinary tract infections were compared with women with antibiotic-susceptible urinary tract infections in terms of demographic, infectious, antepartum, and intrapartum data. The primary outcome was pyelonephritis, defined as a billing code for pyelonephritis plus fever or flank pain. The secondary outcomes were length of stay in the hospital because of pyelonephritis, a composite of pyelonephritis complications (renal abscess, sepsis, and intensive care unit admission), and preterm delivery. The differences in the primary outcome were analyzed using multivariate logistic regression.
A total of 573 women were eligible for inclusion. Of the 573 women, 334 (58%) had gram-negative bacteria on urine culture. Of the 334 cases, 173 (52%) were antibiotic susceptible, 74 (22%) were antibiotic resistant, and 87 (26%) were multidrug resistant. Women with antibiotic-resistant and multidrug-resistant infections were more likely to have hypertension (P=.004), to be Black (P=.03), to have public insurance (P=.002), and to experience more urinary infections (P=.001). Pyelonephritis was more common in women with antibiotic-resistant (adjusted odds ratio, 2.27; 95% confidence interval, 1.08-4.78) and multidrug-resistant (adjusted odds ratio, 3.06; 95% confidence interval, 1.57-5.96) infections than in women with antibiotic-susceptible urinary tract infections. Length of stay, preterm delivery, and pyelonephritis complications did not differ between antibiotic-susceptible and antibiotic-resistant and multidrug-resistant infections.
In an age of increasing antibiotic resistance, more than one-half of pregnant women with bacteriuria experience at least 1 infection with an antibiotic-resistant organism. These resistance patterns have a real clinical impact as pregnant women with antibiotic-resistant gram-negative lower urinary tract infections have an estimated 2- to 3-fold increased odds of developing pyelonephritis.
抗生素的引入显著降低了微生物感染的发病率和死亡率,但抗生素耐药和多药耐药微生物的出现引起了越来越多的临床关注。很少有研究探讨常见产前感染中抗生素耐药的流行情况和影响。
本研究旨在确定尿液培养出抗生素耐药或多药耐药革兰氏阴性菌的孕妇与感染抗生素敏感菌的孕妇相比,是否更有可能发生肾盂肾炎。
这是一项回顾性队列研究,纳入了 2013 年 7 月至 2019 年 5 月期间来自单一医疗系统的无症状菌尿或急性膀胱炎孕妇。将革兰氏阴性抗生素耐药(对 1-2 种抗生素类别的耐药)和多药耐药(对≥3 种抗生素类别的耐药)下尿路感染的孕妇与抗生素敏感的尿路感染孕妇进行比较,比较内容包括人口统计学、感染、产前和产时数据。主要结局为肾盂肾炎,定义为肾盂肾炎的计费代码加上发热或腰痛。次要结局为因肾盂肾炎住院的时间、肾盂肾炎并发症(肾脓肿、败血症和重症监护病房入院)的复合结局以及早产。使用多变量逻辑回归分析主要结局的差异。
共有 573 名妇女符合纳入标准。在 573 名妇女中,334 名(58%)尿液培养出革兰氏阴性菌。在 334 例中,173 例(52%)为抗生素敏感,74 例(22%)为抗生素耐药,87 例(26%)为多药耐药。抗生素耐药和多药耐药感染的妇女更有可能患有高血压(P=.004)、为黑人(P=.03)、有公共保险(P=.002),且更易发生尿路感染(P=.001)。与抗生素敏感的尿路感染妇女相比,抗生素耐药(调整后比值比,2.27;95%置信区间,1.08-4.78)和多药耐药(调整后比值比,3.06;95%置信区间,1.57-5.96)感染的妇女发生肾盂肾炎的可能性更高。抗生素敏感和耐药及多药耐药感染的妇女之间住院时间、早产和肾盂肾炎并发症无差异。
在抗生素耐药日益增加的时代,超过一半的菌尿症孕妇至少有 1 次感染了抗生素耐药菌。这些耐药模式具有实际的临床影响,因为抗生素耐药革兰氏阴性下尿路感染的孕妇发生肾盂肾炎的可能性估计增加了 2-3 倍。